Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56301 - 56325 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	KLF6	1316	upregulated	panobinostat results in increased expression of KLF6 mRNA	10p15.2	A21037
Panobinostat	Approved Investigational	KLHL14	57565	upregulated	panobinostat results in increased expression of KLHL14 mRNA	18q12.1	A21037
Panobinostat	Approved Investigational	KLK8	11202	upregulated	panobinostat results in increased expression of KLK8 mRNA	19q13	A21037
Panobinostat	Approved Investigational	KLRG2	346689	upregulated	panobinostat results in increased expression of KLRG2 mRNA	7q34	A21037
Panobinostat	Approved Investigational	KREMEN1	83999	upregulated	panobinostat results in increased expression of KREMEN1 mRNA	22q12.1	A21037
Panobinostat	Approved Investigational	KRT18	3875	upregulated	panobinostat results in increased expression of KRT18 mRNA	12q13.13	A21037
Panobinostat	Approved Investigational	KRT8	3856	upregulated	panobinostat results in increased expression of KRT8 mRNA	12q13.13	A21037
Panobinostat	Approved Investigational	L1CAM	3897	upregulated	panobinostat results in increased expression of L1CAM mRNA	Xq28	A21037
Panobinostat	Approved Investigational	L1TD1	54596	upregulated	panobinostat results in increased expression of L1TD1 mRNA	1p31.3	A21037
Panobinostat	Approved Investigational	LACC1	144811	upregulated	panobinostat results in increased expression of LACC1 mRNA	13q14.11	A21037
Panobinostat	Approved Investigational	LACTB	114294	upregulated	panobinostat results in increased expression of LACTB mRNA	15q22.2	A21037
Panobinostat	Approved Investigational	LAMA2	3908	upregulated	panobinostat results in increased expression of LAMA2 mRNA	6q22.33	A21037
Panobinostat	Approved Investigational	LAMA4	3910	upregulated	panobinostat results in increased expression of LAMA4 mRNA	6q21	A21037
Panobinostat	Approved Investigational	LAMC2	3918	upregulated	panobinostat results in increased expression of LAMC2 mRNA	1q25.3	A21037
Panobinostat	Approved Investigational	LAMP2	3920	upregulated	panobinostat results in increased expression of LAMP2 mRNA	Xq24	A21037
Panobinostat	Approved Investigational	LAYN	143903	upregulated	panobinostat results in increased expression of LAYN mRNA	11q23.1	A21037
Panobinostat	Approved Investigational	LCTL	197021	downregulated	panobinostat results in decreased expression of LCTL mRNA	15q22.31	A21037
Panobinostat	Approved Investigational	LDHD	197257	upregulated	panobinostat results in increased expression of LDHD mRNA	16q23.1	A21037
Panobinostat	Approved Investigational	LGALS3	3958	upregulated	panobinostat results in increased expression of LGALS3 mRNA	14q22.3	A21037
Panobinostat	Approved Investigational	LHFP	10186	upregulated	panobinostat results in increased expression of LHFP mRNA	13q13.3-q14.11	A21037
Panobinostat	Approved Investigational	LHX2	9355	downregulated	panobinostat results in decreased expression of LHX2 mRNA	9q33.3	A21037
Panobinostat	Approved Investigational	LHX8	431707	upregulated	panobinostat results in increased expression of LHX8 mRNA	1p31.1	A21037
Panobinostat	Approved Investigational	LIFR	3977	upregulated	panobinostat results in increased expression of LIFR mRNA	5p13.1	A21037
Panobinostat	Approved Investigational	LIMCH1	22998	downregulated	panobinostat results in decreased expression of LIMCH1 mRNA	4p13	A21037
Panobinostat	Approved Investigational	LINC00458	100507428	upregulated	panobinostat results in increased expression of LINC00458 mRNA	13q14.3	A21037

Displaying entries 56301 - 56325 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability